From: A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Duration (days)a | IC43 100 μg with adj (N = 104) | IC43 100 μg w/o adj (N = 98) | IC43 200 μg with adj (N = 101) | Placebo (N = 98) | Total (N = 401) |
---|---|---|---|---|---|
Ventilation | 18.5 (13.4) | 18.7 (18.6) | 18.5 (17.2) | 17.9 (14.8) | 18.4 (16.0) |
ICU stay | 26.6 (17.7) | 24.3 (17.8) | 24.0 (16.9) | 23.5 (16.0) | 24.6 (17.1) |
Hospital stayb | 15.2 (20.3) | 13.9 (14.6) | 14.4 (20.9) | 12.4 (17.6) | 14.0 (18.5) |